Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Volumn 45, Issue 6, 2020, Pages 1219-1224

  Ma, Jing ^a   Huo, Xiao Qian ^a   Chen, Xi ^a   Zhu, Wei Xing ^b   Yao, Mei Cun ^c   Qiao, Yan Jiang ^a   Zhang, Yan Ling ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Qingyuan Hospital of Traditional Chinese Medicine Qingyuan 511500   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

2019 nCoV; 3CL hydrolase; angiotensin converting enzyme 2; molecular docking; papain like protease; traditional Chinese medicine

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HERBACEOUS AGENT;

BETACORONAVIRUS; CHINESE MEDICINE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DRUG EFFECT; HUMAN; MOLECULAR DOCKING; PANDEMIC; PRECLINICAL STUDY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; PANDEMICS; PEPTIDYL-DIPEPTIDASE A; PNEUMONIA, VIRAL;

EID: 85082202943     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.19540/j.cnki.cjcmm.20200216.401     Document Type: Article

References (0)